Every earnings call for 532067 — management tone, guidance, KPIs and promise tracking, quarter by quarter.
532067 · 3 transcripts · Healthcare · latest Q4 FY263B Blackbio has 3 earnings calls on record here, a Healthcare company, most recently Q4 FY26. Each quarter is scored on revenue, margins, guidance delivery and the questions management left unanswered — so the gap between what was promised and what was delivered is easy to read.
Consolidated Revenue ₹142 cr; Consolidated EBITDA Margin 40%; Consolidated PAT ₹60 cr. Consolidated revenue of approximately INR142 crores for FY26.
Read full transcript & analysisRevenue (9M FY26, with Coris) ₹99 cr (+53% YoY). Consolidated revenue for 9M FY26 (with Coris) was INR 99.06 crores, up 52.87% YoY from INR 64.80 crores (without Coris) in 9M FY25.
Read full transcript & analysisEBITDA ₹16 cr (+11% YoY). Q1 FY26 Sales reached INR 19.96 crores, marking an 18% year-on-year increase.
Read full transcript & analysis